Global Non-invasive Parenteral Screening Market Growth (Status and Outlook) 2025-2031

September 2025 | 98 pages | ID: GB4ABD18E408EN
LP Information

Abstracts

According to this study, the global Non-invasive Parenteral Screening market size will reach US$ 8527 million by 2031.

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Non-invasive Parenteral Screening Industry Forecast” looks at past sales and reviews total world Non-invasive Parenteral Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-invasive Parenteral Screening sales for 2025 through 2031. With Non-invasive Parenteral Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Parenteral Screening industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Parenteral Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive Parenteral Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Parenteral Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Parenteral Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Parenteral Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Parenteral Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Instruments
• Consumables

Segmentation by Application:

• Diagnostic Laboratories
• Hospitals

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GE Healthcare
• Philips
• Illumina
• Thermo Fisher Scientific
• Roche
• PacBio
• Perkinelmer
• Qiagen
• Agilent Technologies
• BGI Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-invasive Parenteral Screening Market Size (2020-2031)
  2.1.2 Non-invasive Parenteral Screening Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Non-invasive Parenteral Screening by Country/Region (2020, 2024 & 2031)
2.2 Non-invasive Parenteral Screening Segment by Type
  2.2.1 Instruments
  2.2.2 Consumables
2.3 Non-invasive Parenteral Screening Market Size by Type
  2.3.1 Non-invasive Parenteral Screening Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
2.4 Non-invasive Parenteral Screening Segment by Application
  2.4.1 Diagnostic Laboratories
  2.4.2 Hospitals
2.5 Non-invasive Parenteral Screening Market Size by Application
  2.5.1 Non-invasive Parenteral Screening Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)

3 NON-INVASIVE PARENTERAL SCREENING MARKET SIZE BY PLAYER

3.1 Non-invasive Parenteral Screening Market Size Market Share by Player
  3.1.1 Global Non-invasive Parenteral Screening Revenue by Player (2020-2025)
  3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Player (2020-2025)
3.2 Global Non-invasive Parenteral Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NON-INVASIVE PARENTERAL SCREENING BY REGION

4.1 Non-invasive Parenteral Screening Market Size by Region (2020-2025)
4.2 Global Non-invasive Parenteral Screening Annual Revenue by Country/Region (2020-2025)
4.3 Americas Non-invasive Parenteral Screening Market Size Growth (2020-2025)
4.4 APAC Non-invasive Parenteral Screening Market Size Growth (2020-2025)
4.5 Europe Non-invasive Parenteral Screening Market Size Growth (2020-2025)
4.6 Middle East & Africa Non-invasive Parenteral Screening Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Non-invasive Parenteral Screening Market Size by Country (2020-2025)
5.2 Americas Non-invasive Parenteral Screening Market Size by Type (2020-2025)
5.3 Americas Non-invasive Parenteral Screening Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-invasive Parenteral Screening Market Size by Region (2020-2025)
6.2 APAC Non-invasive Parenteral Screening Market Size by Type (2020-2025)
6.3 APAC Non-invasive Parenteral Screening Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Non-invasive Parenteral Screening Market Size by Country (2020-2025)
7.2 Europe Non-invasive Parenteral Screening Market Size by Type (2020-2025)
7.3 Europe Non-invasive Parenteral Screening Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-invasive Parenteral Screening by Region (2020-2025)
8.2 Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2020-2025)
8.3 Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NON-INVASIVE PARENTERAL SCREENING MARKET FORECAST

10.1 Global Non-invasive Parenteral Screening Forecast by Region (2026-2031)
  10.1.1 Global Non-invasive Parenteral Screening Forecast by Region (2026-2031)
  10.1.2 Americas Non-invasive Parenteral Screening Forecast
  10.1.3 APAC Non-invasive Parenteral Screening Forecast
  10.1.4 Europe Non-invasive Parenteral Screening Forecast
  10.1.5 Middle East & Africa Non-invasive Parenteral Screening Forecast
10.2 Americas Non-invasive Parenteral Screening Forecast by Country (2026-2031)
  10.2.1 United States Market Non-invasive Parenteral Screening Forecast
  10.2.2 Canada Market Non-invasive Parenteral Screening Forecast
  10.2.3 Mexico Market Non-invasive Parenteral Screening Forecast
  10.2.4 Brazil Market Non-invasive Parenteral Screening Forecast
10.3 APAC Non-invasive Parenteral Screening Forecast by Region (2026-2031)
  10.3.1 China Non-invasive Parenteral Screening Market Forecast
  10.3.2 Japan Market Non-invasive Parenteral Screening Forecast
  10.3.3 Korea Market Non-invasive Parenteral Screening Forecast
  10.3.4 Southeast Asia Market Non-invasive Parenteral Screening Forecast
  10.3.5 India Market Non-invasive Parenteral Screening Forecast
  10.3.6 Australia Market Non-invasive Parenteral Screening Forecast
10.4 Europe Non-invasive Parenteral Screening Forecast by Country (2026-2031)
  10.4.1 Germany Market Non-invasive Parenteral Screening Forecast
  10.4.2 France Market Non-invasive Parenteral Screening Forecast
  10.4.3 UK Market Non-invasive Parenteral Screening Forecast
  10.4.4 Italy Market Non-invasive Parenteral Screening Forecast
  10.4.5 Russia Market Non-invasive Parenteral Screening Forecast
10.5 Middle East & Africa Non-invasive Parenteral Screening Forecast by Region (2026-2031)
  10.5.1 Egypt Market Non-invasive Parenteral Screening Forecast
  10.5.2 South Africa Market Non-invasive Parenteral Screening Forecast
  10.5.3 Israel Market Non-invasive Parenteral Screening Forecast
  10.5.4 Turkey Market Non-invasive Parenteral Screening Forecast
10.6 Global Non-invasive Parenteral Screening Forecast by Type (2026-2031)
10.7 Global Non-invasive Parenteral Screening Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Non-invasive Parenteral Screening Forecast

11 KEY PLAYERS ANALYSIS

11.1 GE Healthcare
  11.1.1 GE Healthcare Company Information
  11.1.2 GE Healthcare Non-invasive Parenteral Screening Product Offered
  11.1.3 GE Healthcare Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GE Healthcare Main Business Overview
  11.1.5 GE Healthcare Latest Developments
11.2 Philips
  11.2.1 Philips Company Information
  11.2.2 Philips Non-invasive Parenteral Screening Product Offered
  11.2.3 Philips Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Philips Main Business Overview
  11.2.5 Philips Latest Developments
11.3 Illumina
  11.3.1 Illumina Company Information
  11.3.2 Illumina Non-invasive Parenteral Screening Product Offered
  11.3.3 Illumina Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Illumina Main Business Overview
  11.3.5 Illumina Latest Developments
11.4 Thermo Fisher Scientific
  11.4.1 Thermo Fisher Scientific Company Information
  11.4.2 Thermo Fisher Scientific Non-invasive Parenteral Screening Product Offered
  11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Thermo Fisher Scientific Main Business Overview
  11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche Non-invasive Parenteral Screening Product Offered
  11.5.3 Roche Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 PacBio
  11.6.1 PacBio Company Information
  11.6.2 PacBio Non-invasive Parenteral Screening Product Offered
  11.6.3 PacBio Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 PacBio Main Business Overview
  11.6.5 PacBio Latest Developments
11.7 Perkinelmer
  11.7.1 Perkinelmer Company Information
  11.7.2 Perkinelmer Non-invasive Parenteral Screening Product Offered
  11.7.3 Perkinelmer Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Perkinelmer Main Business Overview
  11.7.5 Perkinelmer Latest Developments
11.8 Qiagen
  11.8.1 Qiagen Company Information
  11.8.2 Qiagen Non-invasive Parenteral Screening Product Offered
  11.8.3 Qiagen Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Qiagen Main Business Overview
  11.8.5 Qiagen Latest Developments
11.9 Agilent Technologies
  11.9.1 Agilent Technologies Company Information
  11.9.2 Agilent Technologies Non-invasive Parenteral Screening Product Offered
  11.9.3 Agilent Technologies Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Agilent Technologies Main Business Overview
  11.9.5 Agilent Technologies Latest Developments
11.10 BGI Group
  11.10.1 BGI Group Company Information
  11.10.2 BGI Group Non-invasive Parenteral Screening Product Offered
  11.10.3 BGI Group Non-invasive Parenteral Screening Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 BGI Group Main Business Overview
  11.10.5 BGI Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Non-invasive Parenteral Screening Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Non-invasive Parenteral Screening Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Instruments
Table 4. Major Players of Consumables
Table 5. Non-invasive Parenteral Screening Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Non-invasive Parenteral Screening Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
Table 8. Non-invasive Parenteral Screening Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Non-invasive Parenteral Screening Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)
Table 11. Global Non-invasive Parenteral Screening Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Non-invasive Parenteral Screening Revenue Market Share by Player (2020-2025)
Table 13. Non-invasive Parenteral Screening Key Players Head office and Products Offered
Table 14. Non-invasive Parenteral Screening Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-invasive Parenteral Screening Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Non-invasive Parenteral Screening Market Size Market Share by Region (2020-2025)
Table 19. Global Non-invasive Parenteral Screening Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Non-invasive Parenteral Screening Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Non-invasive Parenteral Screening Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Non-invasive Parenteral Screening Market Size Market Share by Country (2020-2025)
Table 23. Americas Non-invasive Parenteral Screening Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
Table 25. Americas Non-invasive Parenteral Screening Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)
Table 27. APAC Non-invasive Parenteral Screening Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Non-invasive Parenteral Screening Market Size Market Share by Region (2020-2025)
Table 29. APAC Non-invasive Parenteral Screening Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Non-invasive Parenteral Screening Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Non-invasive Parenteral Screening Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Non-invasive Parenteral Screening Market Size Market Share by Country (2020-2025)
Table 33. Europe Non-invasive Parenteral Screening Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Non-invasive Parenteral Screening Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Non-invasive Parenteral Screening Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Non-invasive Parenteral Screening Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Non-invasive Parenteral Screening Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-invasive Parenteral Screening
Table 39. Key Market Challenges & Risks of Non-invasive Parenteral Screening
Table 40. Key Industry Trends of Non-invasive Parenteral Screening
Table 41. Global Non-invasive Parenteral Screening Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Non-invasive Parenteral Screening Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Non-invasive Parenteral Screening Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Non-invasive Parenteral Screening Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. GE Healthcare Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 46. GE Healthcare Non-invasive Parenteral Screening Product Offered
Table 47. GE Healthcare Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. GE Healthcare Main Business
Table 49. GE Healthcare Latest Developments
Table 50. Philips Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 51. Philips Non-invasive Parenteral Screening Product Offered
Table 52. Philips Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Philips Main Business
Table 54. Philips Latest Developments
Table 55. Illumina Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 56. Illumina Non-invasive Parenteral Screening Product Offered
Table 57. Illumina Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Illumina Main Business
Table 59. Illumina Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Non-invasive Parenteral Screening Product Offered
Table 62. Thermo Fisher Scientific Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Roche Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 66. Roche Non-invasive Parenteral Screening Product Offered
Table 67. Roche Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Roche Main Business
Table 69. Roche Latest Developments
Table 70. PacBio Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 71. PacBio Non-invasive Parenteral Screening Product Offered
Table 72. PacBio Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. PacBio Main Business
Table 74. PacBio Latest Developments
Table 75. Perkinelmer Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 76. Perkinelmer Non-invasive Parenteral Screening Product Offered
Table 77. Perkinelmer Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Perkinelmer Main Business
Table 79. Perkinelmer Latest Developments
Table 80. Qiagen Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 81. Qiagen Non-invasive Parenteral Screening Product Offered
Table 82. Qiagen Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Qiagen Main Business
Table 84. Qiagen Latest Developments
Table 85. Agilent Technologies Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 86. Agilent Technologies Non-invasive Parenteral Screening Product Offered
Table 87. Agilent Technologies Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Agilent Technologies Main Business
Table 89. Agilent Technologies Latest Developments
Table 90. BGI Group Details, Company Type, Non-invasive Parenteral Screening Area Served and Its Competitors
Table 91. BGI Group Non-invasive Parenteral Screening Product Offered
Table 92. BGI Group Non-invasive Parenteral Screening Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. BGI Group Main Business
Table 94. BGI Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Non-invasive Parenteral Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive Parenteral Screening Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Non-invasive Parenteral Screening Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Non-invasive Parenteral Screening Sales Market Share by Country/Region (2024)
Figure 8. Non-invasive Parenteral Screening Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Non-invasive Parenteral Screening Market Size Market Share by Type in 2024
Figure 10. Non-invasive Parenteral Screening in Diagnostic Laboratories
Figure 11. Global Non-invasive Parenteral Screening Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 12. Non-invasive Parenteral Screening in Hospitals
Figure 13. Global Non-invasive Parenteral Screening Market: Hospitals (2020-2025) & ($ millions)
Figure 14. Global Non-invasive Parenteral Screening Market Size Market Share by Application in 2024
Figure 15. Global Non-invasive Parenteral Screening Revenue Market Share by Player in 2024
Figure 16. Global Non-invasive Parenteral Screening Market Size Market Share by Region (2020-2025)
Figure 17. Americas Non-invasive Parenteral Screening Market Size 2020-2025 ($ millions)
Figure 18. APAC Non-invasive Parenteral Screening Market Size 2020-2025 ($ millions)
Figure 19. Europe Non-invasive Parenteral Screening Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Non-invasive Parenteral Screening Market Size 2020-2025 ($ millions)
Figure 21. Americas Non-invasive Parenteral Screening Value Market Share by Country in 2024
Figure 22. United States Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Non-invasive Parenteral Screening Market Size Market Share by Region in 2024
Figure 27. APAC Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
Figure 28. APAC Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)
Figure 29. China Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 33. India Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Non-invasive Parenteral Screening Market Size Market Share by Country in 2024
Figure 36. Europe Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
Figure 37. Europe Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)
Figure 38. Germany Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 39. France Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Non-invasive Parenteral Screening Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Non-invasive Parenteral Screening Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Non-invasive Parenteral Screening Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Non-invasive Parenteral Screening Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 52. APAC Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 53. Europe Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 55. United States Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 56. Canada Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 57. Mexico Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 58. Brazil Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 59. China Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 60. Japan Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 61. Korea Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 63. India Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 64. Australia Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 65. Germany Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 66. France Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 67. UK Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 68. Italy Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 69. Russia Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 70. Egypt Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 71. South Africa Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 72. Israel Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 73. Turkey Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)
Figure 74. Global Non-invasive Parenteral Screening Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Non-invasive Parenteral Screening Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Non-invasive Parenteral Screening Market Size 2026-2031 ($ millions)